• Register
  • Login

Iranian Journal of Dermatology

  1. Home
  2. The effect of combination therapy with systemic Meglumine Antimoniate (Glucantime) and Pentoxifylline in the treatment of cutaneous Leishmaniasis

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

The effect of combination therapy with systemic Meglumine Antimoniate (Glucantime) and Pentoxifylline in the treatment of cutaneous Leishmaniasis

Authors

  • G Sadeghian
  • MA Nilforoush Zadeh

Abstract

.

Keywords

  • Cutaneous leishmaniasis
  • Glucantime
  • Pentoxifylline
Iranian Journal of Dermatology
Volume 9, Issue 1 - Serial Number 35
2006
Pages 17-21
Files
  • XML
  • PDF 751.18 K
Share
How to cite
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 55
  • PDF Download: 22

APA

Sadeghian, G., & Nilforoush Zadeh, M. (2006). The effect of combination therapy with systemic Meglumine Antimoniate (Glucantime) and Pentoxifylline in the treatment of cutaneous Leishmaniasis. Iranian Journal of Dermatology, 9(1), 17-21.

MLA

G Sadeghian; MA Nilforoush Zadeh. "The effect of combination therapy with systemic Meglumine Antimoniate (Glucantime) and Pentoxifylline in the treatment of cutaneous Leishmaniasis". Iranian Journal of Dermatology, 9, 1, 2006, 17-21.

HARVARD

Sadeghian, G., Nilforoush Zadeh, M. (2006). 'The effect of combination therapy with systemic Meglumine Antimoniate (Glucantime) and Pentoxifylline in the treatment of cutaneous Leishmaniasis', Iranian Journal of Dermatology, 9(1), pp. 17-21.

VANCOUVER

Sadeghian, G., Nilforoush Zadeh, M. The effect of combination therapy with systemic Meglumine Antimoniate (Glucantime) and Pentoxifylline in the treatment of cutaneous Leishmaniasis. Iranian Journal of Dermatology, 2006; 9(1): 17-21.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

©